NCT05817474

Brief Summary

All anesthetic techniques aim to lessen intra-operative surgical site bleeding because it is a major problem and does not help with precision, surgery time, or postoperative wound healing. The main reason for reoperation and mortality in children who have had tonsillectomies is post-tonsillectomy hemorrhage. Pre-emptive analgesia reduces surgical pain blocking of central sensitization by topical or systemic medications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2022

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2022

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 5, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 18, 2023

Completed
Last Updated

April 21, 2023

Status Verified

April 1, 2023

Enrollment Period

14 days

First QC Date

April 5, 2023

Last Update Submit

April 19, 2023

Conditions

Keywords

TonsillectomyLidocaine

Outcome Measures

Primary Outcomes (1)

  • Postoperative bleeding, pain and postoperative opioid consumption

    Postoperative bleeding, pain and postoperative opioid consumption

    12 month

Study Arms (2)

Group T

EXPERIMENTAL

Group T: received lidocaine (2 %) 2 ml and tranexamic acid 2 ml in each tonsillar bed;

Drug: lidocaine (2 %) 2 ml and tranexamic acid

Group N

PLACEBO COMPARATOR

Group N (Control group): received 4 ml of normal saline in each tonsillar bed.

Drug: lidocaine (2 %) 2 ml and tranexamic acid

Interventions

lidocaine (2 %) 2 ml and tranexamic acid 2 ml in each tonsillar bed

Group NGroup T

Eligibility Criteria

Age4 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Male or female child between 4 and 12 years old
  • ASA one and two, planned for an elective tonsillectomy
  • Patients having 4 or more episodes of tonsillitis in the last year, 5 or more episodes in the previous two years, or 7 episodes in the previous three years.

You may not qualify if:

  • Children with diabetes mellitus, problems of the heart, kidneys, or liver 4-Obstructive sleep apnea syndrome 5-blood disorders, or a propensity to hemorrhage 6-patients suspected of an allergy to the drug being administered, and those undergoing concurrent surgery such as an adenoidectomy or tongue tie.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MEDICIN

Cairo, 11765, Egypt

Location

MeSH Terms

Conditions

Pain, PostoperativePostoperative Hemorrhage

Interventions

LidocaineTranexamic Acid

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsHemorrhage

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCyclohexanecarboxylic AcidsAcids, CarbocyclicCarboxylic Acids

Study Officials

  • abdalla mohamed abdalla, MD

    AZHAR

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
assissant professor of anesthesia

Study Record Dates

First Submitted

April 5, 2023

First Posted

April 18, 2023

Study Start

May 1, 2022

Primary Completion

May 15, 2022

Study Completion

March 1, 2023

Last Updated

April 21, 2023

Record last verified: 2023-04

Locations